• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用人源化单克隆抗体抑制P-选择素和PSGL-1可增加多发性骨髓瘤细胞对硼替佐米的敏感性。

Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib.

作者信息

Muz Barbara, Azab Feda, de la Puente Pilar, Rollins Scott, Alvarez Richard, Kawar Ziad, Azab Abdel Kareem

机构信息

Cancer Biology Division, Department of Radiation Oncology, Washington University in Saint Louis School of Medicine, Saint Louis, MO 63108, USA.

Selexys Pharmaceuticals, 840 Research Parkway, Suite 510, Oklahoma City, OK 73104, USA.

出版信息

Biomed Res Int. 2015;2015:417586. doi: 10.1155/2015/417586. Epub 2015 Oct 11.

DOI:10.1155/2015/417586
PMID:26539491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4619821/
Abstract

Multiple myeloma (MM) is a plasma cell malignancy localized in the bone marrow. Despite the introduction of novel therapies majority of MM patients relapse. We have previously shown that inhibition of P-selectin and P-selectin glycoprotein ligand-1 (PSGL-1) play a key role in proliferation of MM and using small-molecule inhibitors of P-selectin/PSGL-1 sensitized MM cells to therapy. However, these small-molecule inhibitors had low specificity to P-selectin and showed poor pharmacokinetics. Therefore, we tested blocking of P-selectin and PSGL-1 using functional monoclonal antibodies in order to sensitize MM cells to therapy. We have demonstrated that inhibiting the interaction between MM cells and endothelial and stromal cells decreased proliferation in MM cells and in parallel induced loose-adhesion to the primary tumor site to facilitate egress. At the same time, blocking this interaction in vivo led to MM cells retention in the circulation and delayed homing to the bone marrow, thus exposing MM cells to bortezomib which contributed to reduced tumor growth and better mice survival. This study provides a better understanding of the biology of P-selectin and PSGL-1 and their roles in dissemination and resensitization of MM to treatment.

摘要

多发性骨髓瘤(MM)是一种局限于骨髓的浆细胞恶性肿瘤。尽管引入了新型疗法,但大多数MM患者仍会复发。我们之前已经表明,抑制P-选择素和P-选择素糖蛋白配体-1(PSGL-1)在MM增殖中起关键作用,并且使用P-选择素/PSGL-1的小分子抑制剂可使MM细胞对治疗敏感。然而,这些小分子抑制剂对P-选择素的特异性较低,并且药代动力学较差。因此,我们测试了使用功能性单克隆抗体阻断P-选择素和PSGL-1,以使MM细胞对治疗敏感。我们已经证明,抑制MM细胞与内皮细胞和基质细胞之间的相互作用会降低MM细胞的增殖,并同时诱导其与原发性肿瘤部位的松散粘附,以促进其逸出。同时,在体内阻断这种相互作用会导致MM细胞滞留在循环中,并延迟归巢至骨髓,从而使MM细胞暴露于硼替佐米,这有助于减少肿瘤生长并提高小鼠存活率。这项研究有助于更好地理解P-选择素和PSGL-1的生物学特性及其在MM的播散和重新致敏治疗中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85df/4619821/5c2ad3a24bdc/BMRI2015-417586.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85df/4619821/fecbaafceaca/BMRI2015-417586.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85df/4619821/3acc02cfd99a/BMRI2015-417586.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85df/4619821/067b92cb8104/BMRI2015-417586.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85df/4619821/5c2ad3a24bdc/BMRI2015-417586.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85df/4619821/fecbaafceaca/BMRI2015-417586.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85df/4619821/3acc02cfd99a/BMRI2015-417586.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85df/4619821/067b92cb8104/BMRI2015-417586.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85df/4619821/5c2ad3a24bdc/BMRI2015-417586.004.jpg

相似文献

1
Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib.使用人源化单克隆抗体抑制P-选择素和PSGL-1可增加多发性骨髓瘤细胞对硼替佐米的敏感性。
Biomed Res Int. 2015;2015:417586. doi: 10.1155/2015/417586. Epub 2015 Oct 11.
2
P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment.P-选择素糖蛋白配体调节多发性骨髓瘤细胞与骨髓微环境的相互作用。
Blood. 2012 Feb 9;119(6):1468-78. doi: 10.1182/blood-2011-07-368050. Epub 2011 Nov 16.
3
Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis.内皮P-选择素糖蛋白配体1在慢性小鼠回肠炎中的关键作用
J Exp Med. 2006 Apr 17;203(4):907-17. doi: 10.1084/jem.20052530. Epub 2006 Mar 27.
4
P-selectin glycoprotein ligand-1 mediates rolling of mouse bone marrow-derived mast cells on P-selectin but not efficiently on E-selectin.P-选择素糖蛋白配体-1介导小鼠骨髓来源的肥大细胞在P-选择素上滚动,但在E-选择素上滚动效率不高。
Eur J Immunol. 1997 Jun;27(6):1339-45. doi: 10.1002/eji.1830270607.
5
PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma.PSGL-1/selectin 和 ICAM-1/CD18 的相互作用参与骨髓瘤中巨噬细胞诱导的耐药性。
Leukemia. 2013 Mar;27(3):702-10. doi: 10.1038/leu.2012.272. Epub 2012 Sep 21.
6
Blockade of PSGL-1 attenuates CD14+ monocytic cell recruitment in intestinal mucosa and ameliorates ileitis in SAMP1/Yit mice.阻断PSGL-1可减少肠道黏膜中CD14+单核细胞的募集,并改善SAMP1/Yit小鼠的回肠炎。
J Leukoc Biol. 2005 Mar;77(3):287-95. doi: 10.1189/jlb.0204104. Epub 2004 Nov 29.
7
A human colon carcinoma cell line exhibits adhesive interactions with P-selectin under fluid flow via a PSGL-1-independent mechanism.一种人结肠癌细胞系在流体流动条件下通过一种不依赖P-选择素糖蛋白配体-1(PSGL-1)的机制与P-选择素表现出黏附相互作用。
Am J Pathol. 1996 Nov;149(5):1661-73.
8
Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta1 and beta2 integrins.血小板与单核细胞的结合通过上调β1和β2整合素的表达及功能来增强单核细胞的黏附特性。
J Leukoc Biol. 2006 Mar;79(3):499-507. doi: 10.1189/jlb.0605318. Epub 2006 Jan 13.
9
P-selectin glycoprotein ligand-1 mediates L-selectin-independent leukocyte rolling in high endothelial venules of peripheral lymph nodes.P-选择素糖蛋白配体-1在外周淋巴结的高内皮微静脉中介导不依赖L-选择素的白细胞滚动。
Int Immunol. 2007 Mar;19(3):321-9. doi: 10.1093/intimm/dxl149. Epub 2007 Jan 30.
10
L-selectin ligands expressed by human leukocytes are HECA-452 antibody-defined carbohydrate epitopes preferentially displayed by P-selectin glycoprotein ligand-1.人类白细胞表达的L-选择素配体是由HECA-452抗体定义的碳水化合物表位,优先由P-选择素糖蛋白配体-1展示。
J Immunol. 1999 Nov 1;163(9):5070-8.

引用本文的文献

1
Targeting the P-selectin/PSGL-1 pathway: discovery of disease-modifying therapeutics for disorders of thromboinflammation.靶向P-选择素/PSGL-1通路:发现用于血栓性炎症疾病的疾病修饰疗法。
Blood Vessel Thromb Hemost. 2024 Jun 18;1(3):100015. doi: 10.1016/j.bvth.2024.100015. eCollection 2024 Sep.
2
1,8-Cineole inhibits platelet-leukocyte aggregate formation by reducing P-selectin expression.1,8-桉叶素通过降低P-选择素的表达来抑制血小板-白细胞聚集体的形成。
Front Pharmacol. 2025 Jun 5;16:1546157. doi: 10.3389/fphar.2025.1546157. eCollection 2025.
3
Comprehensive analysis of SELPLG as a potential immunotherapy target and prognostic biomarker in oncology.

本文引用的文献

1
Relationship of P-selectin glycoprotein ligand-1 to prognosis in patients with multiple myeloma.P-选择素糖蛋白配体-1与多发性骨髓瘤患者预后的关系
Clin Lymphoma Myeloma Leuk. 2015 Mar;15(3):164-70. doi: 10.1016/j.clml.2014.09.005. Epub 2014 Sep 28.
2
Molecularly targeted therapies in multiple myeloma.多发性骨髓瘤的分子靶向治疗
Leuk Res Treatment. 2014;2014:976567. doi: 10.1155/2014/976567. Epub 2014 Apr 16.
3
Contemporary drug therapies for multiple myeloma.多发性骨髓瘤的当代药物疗法。
对SELPLG作为肿瘤学中潜在免疫治疗靶点和预后生物标志物的综合分析。
Discov Oncol. 2025 Jun 12;16(1):1073. doi: 10.1007/s12672-025-02934-0.
4
Potential new cancer biomarkers revealed by quantum chemistry associated with bioinformatics in the study of selectin polymorphisms.在选择素多态性研究中,量子化学与生物信息学相关联揭示的潜在新型癌症生物标志物。
Heliyon. 2024 Mar 27;10(7):e28830. doi: 10.1016/j.heliyon.2024.e28830. eCollection 2024 Apr 15.
5
PSGL-1 decorated with sialyl Lewis promotes high affinity binding of myeloma cells to P-selectin but is dispensable for E-selectin engagement.PSGL-1 糖基化修饰促进骨髓瘤细胞与 P 选择素的高亲和力结合,但对于 E 选择素的结合则是可有可无的。
Sci Rep. 2024 Jan 19;14(1):1756. doi: 10.1038/s41598-024-52212-2.
6
A non-human primate derived anti-P-selectin glycoprotein ligand-1 antibody curtails acute pancreatitis by alleviating the inflammatory responses.一种源自非人灵长类动物的抗P-选择素糖蛋白配体-1抗体通过减轻炎症反应来减轻急性胰腺炎。
Acta Pharm Sin B. 2023 Nov;13(11):4461-4476. doi: 10.1016/j.apsb.2023.07.028. Epub 2023 Jul 31.
7
Sialofucosylation Enables Platelet Binding to Myeloma Cells via P-Selectin and Suppresses NK Cell-Mediated Cytotoxicity.唾液岩藻糖基化通过P-选择素使血小板与骨髓瘤细胞结合,并抑制自然杀伤细胞介导的细胞毒性。
Cancers (Basel). 2023 Apr 5;15(7):2154. doi: 10.3390/cancers15072154.
8
Aberrant Sialylation in Cancer: Therapeutic Opportunities.癌症中的异常唾液酸化:治疗机遇
Cancers (Basel). 2022 Aug 31;14(17):4248. doi: 10.3390/cancers14174248.
9
Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma.来自血液和骨髓移植临床研究网络骨髓瘤协作组关于多发性骨髓瘤免疫和细胞治疗的研讨会会议记录。
Transplant Cell Ther. 2022 Aug;28(8):446-454. doi: 10.1016/j.jtct.2022.05.019. Epub 2022 May 21.
10
Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell-mediated tumor responses.靶向多发性骨髓瘤的高唾液酸化代表了一种增强 NK 细胞介导的肿瘤反应的新方法。
Blood Adv. 2022 Jun 14;6(11):3352-3366. doi: 10.1182/bloodadvances.2021006805.
Drugs Today (Barc). 2013 Sep;49(9):563-73. doi: 10.1358/dot.2013.49.9.2020941.
4
PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma.PSGL-1/selectin 和 ICAM-1/CD18 的相互作用参与骨髓瘤中巨噬细胞诱导的耐药性。
Leukemia. 2013 Mar;27(3):702-10. doi: 10.1038/leu.2012.272. Epub 2012 Sep 21.
5
P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment.P-选择素糖蛋白配体调节多发性骨髓瘤细胞与骨髓微环境的相互作用。
Blood. 2012 Feb 9;119(6):1468-78. doi: 10.1182/blood-2011-07-368050. Epub 2011 Nov 16.
6
Interactions between endothelial selectins and cancer cells regulate metastasis.内皮选择素与癌细胞之间的相互作用调节转移。
Front Biosci (Landmark Ed). 2011 Jun 1;16(9):3233-51. doi: 10.2741/3909.
7
FGFR3 is overexpressed waldenstrom macroglobulinemia and its inhibition by Dovitinib induces apoptosis and overcomes stroma-induced proliferation.成纤维细胞生长因子受体 3 在华氏巨球蛋白血症中过表达,多韦替尼抑制其表达可诱导细胞凋亡,并克服基质诱导的增殖。
Clin Cancer Res. 2011 Jul 1;17(13):4389-99. doi: 10.1158/1078-0432.CCR-10-2772. Epub 2011 Apr 26.
8
GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice.GMI-1070,一种新型的泛选择素拮抗剂,可逆转镰状细胞小鼠的急性血管闭塞。
Blood. 2010 Sep 9;116(10):1779-86. doi: 10.1182/blood-2009-12-260513. Epub 2010 May 27.
9
Thrombopoietic cytokine and P-selectin levels in patients with multiple myeloma undergoing autologous stem cell transplantation: decrease in posttransplantation P-selectin levels might predict the degree of maximum response.
Clin Lymphoma Myeloma. 2009 Jun;9(3):229-33. doi: 10.3816/CLM.2009.n.045.
10
P-selectin glycoprotein ligand-1 as a potential target for humoral immunotherapy of multiple myeloma.P-选择素糖蛋白配体-1作为多发性骨髓瘤体液免疫治疗的潜在靶点。
Curr Cancer Drug Targets. 2009 Aug;9(5):617-25. doi: 10.2174/156800909789056971.